Published in Medical Letter on the CDC and FDA, June 26th, 2011
"In this report we describe studies examining RepliVAX WN safety, potency, and efficacy in a non-human primate model of WNV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.